BLOG

Thursday, January 24, 2019

Glenmark Pharma gets USFDA nod for seizure treatment drug

Shares of Glenmark Pharmaceuticals were trading 1.02% higher at Rs 656.10 apiece on the BSE

from Companies http://bit.ly/2TaCJvR
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO

However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...